Primary HLH and Gamifant Educational Program
May 17, 6:00 PM – 7:00 PM EDT
Boston, 900 Boylston St, Boston, MA 02115, USA
Join Sobi and other healthcare professionals for an in-person presentation featuring an overview of primary hemophagocytic lymphohistiocytosis (HLH) diagnosis and treatment with Gamifant. The session will include an in-depth look at Gamifant as an interferon gamma–blocking antibody treatment option and a Q&A segment for additional information.
Yorumlar